Metabolomics and mitochondrial dysfunction in cardiometabolic disease

Area of Science:

• Biochemistry
• Metabolomics
• Mitochondrial Biology

Background:

• Circulating metabolites indicate systemic metabolic dysfunction and are implicated in cardiometabolic diseases (CMDs).
• Mitochondrial metabolic pathways like glycolysis and fatty acid oxidation are altered in CMDs.
• Mitochondrial DNA mutations and epigenetic factors contribute to metabolic dysregulation.

Approach:

• This review synthesizes current knowledge on metabolite interactions within mitochondria during CMDs.
• It examines the impact of metabolites on cellular and systemic functions.
• The review highlights the role of metabolomic analyses in advancing precision medicine.

Key Points:

• Metabolite-protein interactions and epigenetic regulation influence cellular and circulating metabolism.
• Mitochondrial dysfunction, driven by factors including mtDNA mutations, is central to CMD pathogenesis.
• Metabolomics provides a powerful tool for understanding disease mechanisms and developing targeted therapies.

Conclusions:

• Understanding metabolite dynamics in mitochondria is crucial for CMD research.
• Metabolomic profiling is essential for the future of precision cardiometabolic medicine.
• Integrating metabolomic insights can enhance translational research and clinical applications for CMDs.